BHC.TO
Bausch Health Companies Inc
Price:  
8.09 
CAD
Volume:  
375,021.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BHC.TO WACC - Weighted Average Cost of Capital

The WACC of Bausch Health Companies Inc (BHC.TO) is 8.6%.

The Cost of Equity of Bausch Health Companies Inc (BHC.TO) is 24.80%.
The Cost of Debt of Bausch Health Companies Inc (BHC.TO) is 9.45%.

Range Selected
Cost of equity 15.90% - 33.70% 24.80%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 7.20% - 11.70% 9.45%
WACC 6.3% - 10.9% 8.6%
WACC

BHC.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 2.51 4.84
Additional risk adjustments 0.0% 0.5%
Cost of equity 15.90% 33.70%
Tax rate 25.90% 26.50%
Debt/Equity ratio 9.83 9.83
Cost of debt 7.20% 11.70%
After-tax WACC 6.3% 10.9%
Selected WACC 8.6%

BHC.TO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for BHC.TO:

cost_of_equity (24.80%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (2.51) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.